Innovative Medicines Canada
55 Metcalfe Street
About Innovative Medicines CanadaInnovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.
6 articles with Innovative Medicines Canada
The following statement can be attributed to Innovative Medicines Canada President, Pamela Fralick.
Innovative Medicines Canada Welcomes ISED Roundtable Recommendations for Health & Biosciences Sector
Innovative Medicines Canada (IMC) welcomes the recommendations made by the Government of Canada's Health/Biosciences Economic Strategy Table (HBEST) Report released today.
Innovative Medicines Canada congratulates the new Ontario Minister of Health and Long-Term Care, Christine Elliott, on moving decisively to revamp OHIP+.
The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada.
In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the creation of the Ontario Drug and Dental Program and the expansion of OHIP + to seniors.
Innovative Medicines Canada Welcomes Akcea Therapeutics Canada And Ipsen Biopharmaceuticals Canada As Its Newest Members